Saylor is content managing editor for Urology Times.
New urology products and services from Symtelligence Medical Informatics, LABORIE, Metamark Genetics, the MediSafe Project, and Olympus
New York-weShare is a new Web and smartphone application designed to improve treatment, decision making, and communication between patients and urologists, according to Symptelligence Medical Informatics. Patients use the app to generate a personal “weScore” (as shown in photo) prior to visiting their urologist. The weScore quantifies the patient’s urinary health through the combination of patient responses to a proprietary questionnaire, a 24-hour urination diary, the AUA Symptom Score, and other standardized scoring methods. The weShare patient data is automatically available for physicians to view both a Physician and Admin Portal online via a secure login. The app, the product of a new distribution partnership between Symptelligence Medical Informatics and LABORIE, was launched at the AUA annual meeting in Orlando, FL.
For more information, visit www.symptelligence.com.
Cambridge, MA-Metamark Genetics, Inc. has initiated clinical use of its ProMark prognostic test to help guide the medical management of patients with early-stage prostate cancer. The test measures the amount of specific protein biomarkers obtained by needle biopsy from regions of prostate tissue where the biomarkers are altered during tumor formation. These “regions of interest” are rendered as intact, paraffin-embedded tissue sections. Quantitative measurements of the biomarkers are then determined by means of imaging technology that is digitized and fully automated. At the recent American Society of Clinical Oncology annual meeting in Chicago, results from a clinical validation study found that ProMark achieved its primary endpoint by accurately differentiating between aggressive and non-aggressive forms of prostate cancer at early stages of disease.
For more information, visit www.metamarkgenetics.com.
Haifa, Israel-Version 3.0 of the medication management platform MediSafe recently launched for iOS and Android. The app allows physicians to send “automatic prescriptions” with take-as-directed instructions directly to patients. Physicians who send an email to email@example.com will work directly with MediSafe in a closed program to send patients secure invites to download the app pre-installed with their medications and optional information such as dosage, the physician’s ID, and how to take medications with/without food. Other features include an upgraded “Med Cabinet” for all medications (“as needed” as well as regularly scheduled); a “Pet Profiles” section for patients to keep track of pet medications; and redesigned user interface and flow.
For more information, visit www.MediSafeProject.com.
Center Valley, PA-Olympus recently added online demonstrations of PlasmaButton Technology to its video library of digital content.The PlasmaButton vaporization electrode is a device used for minimally invasive treatment of BPH. In the Olympus Urology Video Center, online visitors can now access demonstrations of transurethral vaporization of prostate and transurethral vaporization of bladder tumor procedures.
For more information, visit www.olympusamerica.com.
Subscribe to Urology Times to get monthly news from the leading news source for urologists.